specifically increase hepatitis C virus RNA-replication." PLoS One 7 (4): e36029. Epub 2012 Apr 25. Lachmann N*, Czarnecki K* , Brennig S, Phaltane R, Heise M, Heinz N, Kempf H, Dilloo D, Kaever V, Schambach

Rossdam C, Schwabbauer M, Kloos D, von Kaisenberg C, Schambach A, Buettner FFR, Janciauskiene S, Lachmann N, Moritz T. Gene Ther. 2021 Jul 19. doi: 10.1038/s41434-021-00269-3. Online ahead of print. PMID:

Abeln, M., Merkert, S., Kühnel, M.P., Hartmann, D., Jonigk, D., Thum, T., Kispert, A., Milsom M.D., Lachmann, N. (2020). A 3D iPSC-differentiation model identifies interleukin-3 as a regulator of early human

Nguyen AH, Abeln M, Merkert S, Kühnel MP , Hartmann D, Jonigk D , Thum T, Kispert A, Milsom MD, Lachmann N. A 3D iPSC-differentiation model identifies interleukin-3 as a regulator of early human hematopoietic

factor (C19orf10) mediates cardiac repair following myocardial infarction. Nat Med 21, 140-149. 44. Lachmann, N., Ackermann, M., Frenzel, E., Liebhaber, S., Brennig, S., Happle, C., Hoffmann, D., Klimenkova

FC, Goethe R, Jonigk D, Förster R, Gentner B, Casanova JL, Bustamante J, Schambach A, Kalinke U, Lachmann N. Hematopoietic stem cell gene therapy for IFNγR1 deficiency protects mice from mycobacterial

MacDonald MR, Boisson-Dupuis S, Marr N, Tangye SG, Di Santo JP, Zhang Q, Zhang S, Rice CM, Béziat V, Lachmann N, Langlais D, Casanova J, Gros P, Bustamante J. Human IRF1 governs macrophagic IFN-γ immunity to